Investigating Safety, Tolerability and Efficacy of AZD5363 in Prostate Cancer. (PYRUS)

This study is currently recruiting participants.
Verified March 2014 by AstraZeneca
Sponsor:
Information provided by (Responsible Party):
AstraZeneca
ClinicalTrials.gov Identifier:
NCT01692262
First received: September 19, 2012
Last updated: March 19, 2014
Last verified: March 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: February 2015
  Estimated Primary Completion Date: May 2014 (Final data collection date for primary outcome measure)